Mephyton

Jaundice, Obstructive, long-acting anticoagulant rodenticides, Vitamin K Deficiency + 17 more

Treatment

10 FDA approvals

18 Active Studies for Mephyton

Treatment for

Jaundice, Obstructive

What is Mephyton

PhylloquinoneThe Generic name of this drug

Treatment SummaryVitamin K1 (also known as phylloquinone or phytonadione) is a fat-soluble vitamin that helps the body form clotting factors II, VII, IX, and X. It is used to treat clotting disorders caused by a lack of vitamin K. This vitamin has been available since 1939 and was approved by the FDA before 1955.

Mephytonis the brand name

image of different drug pills on a surface

Mephyton Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Mephyton

Phylloquinone

1955

65

Approved as Treatment by the FDA

Phylloquinone, also known as Mephyton, is approved by the FDA for 10 uses including Jaundice, Obstructive and Hypoprothrombinemia .

Jaundice, Obstructive

Used to treat Jaundice, Obstructive in combination with Taurocholic acid

Hypoprothrombinemia

Fistula, Biliary

Used to treat Fistula, Biliary in combination with Taurocholic acid

antibacterial therapy

Biliary Fistula

Used to treat Fistula, Biliary in combination with Taurocholic acid

hemorrhagic disease of the newborn

Hypoprothrombinemias

Jaundice, Obstructive

Used to treat Jaundice, Obstructive in combination with Taurocholic acid

Hemorrhagic Disease of Newborn

Salicylate

Effectiveness

How Mephyton Affects PatientsPhylloquinone is a vitamin K used to treat problems with blood clotting due to a lack of or reduced activity of vitamin K. It stays in the body for a long time and is safe to take in large doses. People taking this medication should have their prothrombin time monitored, and healthcare professionals should be aware of the risk of allergic reactions with injections.

How Mephyton works in the bodyVitamin K helps the body form blood clots by helping clotting proteins bind to calcium ions. This allows them to become active and be released into the blood, which helps stop bleeding. Vitamin K might also help prevent joint calcification, increased bone density, and reducing the risk of vascular calcification. These benefits are still being studied.

When to interrupt dosage

The suggested portion of Mephyton is contingent upon the diagnosed condition, like Sprue, Vitamin supplementation and Ulcerative Colitis. The measure of dosage is contingent upon the method of delivery outlined in the table beneath.

Condition

Dosage

Administration

Celiac Disease

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Crohn Disease

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Anticoagulant Therapy

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Blood Coagulation Disorders

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

vitamin K

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Biliary Fistula

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Jaundice, Obstructive

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

long-acting anticoagulant rodenticides

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Vitamin K Deficiency

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

hemorrhagic disease of the newborn

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Hypoprothrombinemias

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Intestinal resection

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Hemorrhagic Disease of Newborn

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Salicylate

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Cystic Fibrosis

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Vitamin supplementation

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Ulcerative Colitis

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Vitamin supplementation therapy

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Celiac Disease

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

antibacterial therapy

, 5.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.0 mg, 0.2 mg/mL, 0.015 mg/mL, 0.15 mg/mL, 0.2 mg, 0.02 mg, 0.08 mg, 0.15 mg, 0.02 mg/mL, 0.1 mg/mL

, Oral, Tablet, Tablet - Oral, Parenteral, Injection, emulsion, Injection, emulsion - Parenteral, Intramuscular; Parenteral; Subcutaneous, Injection, solution, Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, emulsion - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Emulsion, Emulsion - Intramuscular; Intravenous; Subcutaneous, Intramuscular, Liquid - Intramuscular, Liquid, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, solution - Intravenous, Capsule, Capsule - Oral, Solution - Parenteral, Injection, powder, lyophilized, for solution, Injection, emulsion - Intramuscular; Parenteral; Subcutaneous, Liquid - Intravenous, Kit, Kit - Oral, Injection, Injection - Intravenous, Solution / drops, Solution / drops - Oral

Warnings

Mephyton has one contraindication, so it must not be utilized when encountering the conditions in the following table.Mephyton Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Phylloquinone may interact with Pulse Frequency

There are 20 known major drug interactions with Mephyton.

Common Mephyton Drug Interactions

Drug Name

Risk Level

Description

(R)-warfarin

Major

The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Phylloquinone.

(S)-Warfarin

Major

The therapeutic efficacy of (S)-Warfarin can be decreased when used in combination with Phylloquinone.

4-hydroxycoumarin

Major

The therapeutic efficacy of 4-hydroxycoumarin can be decreased when used in combination with Phylloquinone.

Acenocoumarol

Major

The therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Phylloquinone.

Clorindione

Major

The therapeutic efficacy of Clorindione can be decreased when used in combination with Phylloquinone.

Mephyton Toxicity & Overdose RiskTaking too much Vitamin K1 can be dangerous and can cause adverse reactions, particularly when administered intravenously. The toxic dose of Vitamin K1 in mice is 1170 mg/kg when administered intravenously, and more than 24180 mg/kg when taken orally. If someone has overdosed on Vitamin K1, they should receive appropriate care and treatment.

Mephyton Novel Uses: Which Conditions Have a Clinical Trial Featuring Mephyton?

100 active trials are currently in progress to assess the potential of Mephyton in alleviating Crohn Disease, Hemorrhagic Disease of the Newborn, and Obstructive Jaundice.

Condition

Clinical Trials

Trial Phases

Ulcerative Colitis

15 Actively Recruiting

Phase 3, Not Applicable, Phase 2, Phase 1

Jaundice, Obstructive

0 Actively Recruiting

Blood Coagulation Disorders

2 Actively Recruiting

Phase 1

Vitamin K Deficiency

0 Actively Recruiting

Cystic Fibrosis

0 Actively Recruiting

Vitamin supplementation

0 Actively Recruiting

Crohn Disease

0 Actively Recruiting

antibacterial therapy

0 Actively Recruiting

Hemorrhagic Disease of Newborn

0 Actively Recruiting

Celiac Disease

0 Actively Recruiting

Hypoprothrombinemias

0 Actively Recruiting

vitamin K

0 Actively Recruiting

hemorrhagic disease of the newborn

0 Actively Recruiting

Vitamin supplementation therapy

0 Actively Recruiting

long-acting anticoagulant rodenticides

0 Actively Recruiting

Celiac Disease

0 Actively Recruiting

Salicylate

0 Actively Recruiting

Anticoagulant Therapy

2 Actively Recruiting

Phase 4, Not Applicable

Intestinal resection

0 Actively Recruiting

Biliary Fistula

0 Actively Recruiting

Mephyton Reviews: What are patients saying about Mephyton?

3.3Patient Review

2/5/2009

Mephyton for Decreased Blood-Clotting from Low Vitamin K

This treatment helped me a lot, but I still experienced some side effects.

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about mephyton

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the side effects of vitamin K injection?

"The following effects may occur at the injection site: pain, swelling, or soreness. You may also experience temporary flushing, taste changes, dizziness, rapid heartbeat, sweating, shortness of breath, or bluish lips/skin/nails. If any of these effects persist or worsen, tell your doctor or pharmacist promptly."

Answered by AI

Is phytonadione the generic name?

"Mephyton is a prescription drug used to treat various medical conditions. These include nutritional deficiencies, a low level of blood clotting factors, and reversing the effects of Warfarin. Mephyton may be used alone or in conjunction with other medications. It belongs to a class of drugs known as Hemostatics, which are vitamins that help promote blood clotting."

Answered by AI

What is Mephyton used for?

"Mephyton is used to prevent bleeding when blood clotting is impaired due to low levels of vitamin K or reduced activity of vitamin K."

Answered by AI

What is the generic name of vitamin K?

"Phytonadione is used to prevent bleeding in people who have blood clotting problems or too little vitamin K in their bodies. Phytonadione is a type of vitamin medication."

Answered by AI

Clinical Trials for Mephyton

Image of McMaster University in Hamilton, Canada.

Dietary Interventions for Inflammatory Bowel Disease

Hamilton, Canada

"This trial aims to investigate how various diets, such as intermittent fasting, the Mediterranean diet, and the Low FODMAP diet, impact individuals with inflammatory bowel disease (IBD). The goal is to

Waitlist Available

McMaster University

Image of University of Chicago in Chicago, United States.

Therapy De-escalation for Ulcerative Colitis

This trial aims to understand how to best treat people with ulcerative colitis. They will compare patients who are in remission and continue their medication to those who decrease or stop their medication. The goal

Waitlist Available

University of ChicagoDavid T Rubin, MD

Image of Altasciences in Montreal, Canada.

PALI-2108 for Ulcerative Colitis

Montreal, Canada

This trial is testing a new oral medication, PALI-2108, for treating ulcerative colitis (UC). The medication targets the intestines and becomes active in the colon, reducing the risk

AltasciencesMitchell L Jones, MD, PhDAltasciences Company Inc.

Image of University of Pennsylvania in Philadelphia, United States.

Self-Help Interventions for Crohn's Disease

Philadelphia, PA

This trial is looking at different ways to help patients with moderate-to-severe IBD improve their ability to manage their condition and reduce disability. Participants will receive four different self-help resources for free - a

Waitlist Available

University of Pennsylvania

Have you considered Mephyton clinical trials? We made a collection of clinical trials featuring Mephyton, we think they might fit your search criteria.

Explore trials for Mephyton

Image of Oklahoma Cancer Specialists and Research Institute in Tulsa, United States.

HMPL-523 for Low Platelet Count

"This trial will test the safety, side effects, and effectiveness of HMPL-523 in adults with ITP at multiple locations with full transparency about the treatment being administered."

Center for Cancer and Blood Disorders (+9 Sites)William Schelman, MD, PhDHutchmed

Image of Tyler Research Institute, LLC in Tyler, United States.

Vixarelimab in Patients With Moderate to Severe Ulcerative Colitis

This trial is testing a new medication called vixarelimab to help people with moderate to severe Ulcerative Colitis who haven't had success with other treatments. The study will check if the medication can reduce symptoms and help patients feel better over time.

Travel Is Reimbursed

Tyler Research Institute, LLC (+19 Sites)Clinical TrialGenentech, Inc.

Image of Tandem Clinical Research, Marrero in Marrero, United States.

APL-1401 for Ulcerative Colitis

This trial tests a new drug, APL-1401, taken daily by mouth, on patients with severe Ulcerative Colitis. It aims to find the safest and most effective dose over a few weeks.

No Cost For Treatment

New Hope Research Development (+4 Sites)Qiuyue QUJiangsu Yahong Meditech Co., Ltd aka Asieris

Image of Medrasa Clinical Research- Site Number : 8400039 in Sherman, United States.

Dupilumab for Ulcerative Colitis

This trial tests dupilumab, a medication that reduces inflammation, in people with moderate to severe Ulcerative Colitis who have a specific type of immune response. The goal is to see if it can help reduce their symptoms by blocking proteins that cause inflammation.

Wellness Clinical Research (WCR)-Site Number:8400009 (+51 Sites)Clinical Sciences & OperationsSanofi

Have you considered Mephyton clinical trials? We made a collection of clinical trials featuring Mephyton, we think they might fit your search criteria.

Explore trials for Mephyton

Image of Clinical Study Site in Witchita, United States.

MORF-057 for Ulcerative Colitis

This trial is testing a new medication called MORF-057 in adults with serious Ulcerative Colitis. The goal is to see if it can reduce inflammation in the gut and help the colon heal. Patients who don't respond well to current treatments might benefit from this new option.

Waitlist Available

Clinical Study Site (+16 Sites)Morphic Therapeutic, Inc

Image of BVL Clinical Research Site Number : 8400015 in Liberty, United States.

SAR443122 for Ulcerative Colitis

This trial is testing SAR443122, a new drug, to see if it can help people with moderate to severe ulcerative colitis by reducing gut inflammation and controlling symptoms. The study will last over a year and includes different phases to assess the drug's effectiveness and safety.

Digestive Health Associates - Rowan Diagnostic Clinic-Site Number:8400003 (+26 Sites)Sanofi

Image of Cotton O'Neil Clinical Research Center in Topeka, United States.

ABX464 for Ulcerative Colitis

This trial studies how well a new drug works to treat ulcerative colitis in people who aren't responding to other treatments.

Tyler Research Institute (+60 Sites)Severine Vermeire, MD, PhDAbivax S.A.

Image of Yale New Haven Hospital in New Haven, United States.

Cognitive Behavioral Therapy vs. Sudarshan Kriya Yoga for Depression in IBD

This trial is testing if talk therapy (CBT) or yoga breathing exercises (SKY) can help reduce anxiety and depression in people with Crohn's disease. The study will compare the effects of these treatments on mental health, quality of life, pain, and fatigue. Yoga has several mechanisms that make it a promising treatment for depression and anxiety, including physical activity, behavioural activation, and mindfulness.

Yale New Haven HospitalJill Gaidos, MD, FACG

Have you considered Mephyton clinical trials? We made a collection of clinical trials featuring Mephyton, we think they might fit your search criteria.

Explore trials for Mephyton

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

About Us Treatment Support Dossier Update A Trial Listing

Conditions

Retinitis Pigmentosa

Spinal Cord Injury

Essential Tremor

Pancreatic Cancer

Locations

Psychology Related

Bipolar Disorder

Eating Disorder

Treatments

Platelet-Rich Plasma

Cities

Terms of Service Privacy Policy Security